
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for RELV and 80,000+ other tickers.
See exactly how RELV's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RELV and 80,000+ other tickers.
Reliv' International, Inc. develops, manufactures, and markets proprietary nutritional supplements. The company offers joint health, protein, gluten free, targeted solutions, blood sugar support, cellular health, cognitive functions and focus, cholesterol support, kid’s nutrition, digestive health, discomfort, energy, aging, heart health, hemp, and immune support products. It also provides multivitamins, omega 3s, probiotics, weight management, dairy and soy free, vegetarian, and vegan products. The company offers its products under the fibrestore, Reliv Classic, Innergize!, and LunaRich C…

Risk and Volatility Achaogen has a beta of -0.81, suggesting that its stock price is 181% less volatile than the S&P 500. Comparatively, Reliv' International has a beta of -0.04, suggesting that its stock price is 104% less volatile than the S&P 500. Earnings and Valuation This table compares Achaogen and Reliv' International"s gross revenue,

CHESTERFIELD, Mo., Dec. 4, 2020 /PRNewswire/ -- Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements that promote optimal health, today announced an update to its plan to suspend its obligations to file periodic and current reports and other...

CHESTERFIELD, Mo., Nov. 13, 2020 /PRNewswire/ -- Reliv International, Inc. (NASDAQ:RELV), a marketer of nutritional supplements that promote optimal health, today reported its financial results for the third quarter of 2020. Reliv reported net sales of $8.7 million for the third quarter...